| 1 | WuXi Biologics (Cayman) Inc | N/A | 8.87% | 32,450 |
| 2 | Changchun High and New Technology Industry Group Inc Class A | N/A | 7.91% | 8,377 |
| 3 | Chongqing Zhifei Biological Products Co Ltd Class A | N/A | 7.71% | 24,950 |
| 4 | Walvax Biotechnology Co Ltd Class A | N/A | 7.60% | 42,000 |
| 5 | CSPC Pharmaceutical Group Ltd | N/A | 7.18% | 192,300 |
| 6 | Shanghai RAAS Blood Products Co Ltd Class A | N/A | 4.94% | 103,100 |
|
| 7 | Beijing Tiantan Biological Products Corp Ltd Class A | N/A | 4.76% | 28,400 |
| 8 | Hualan Biological Engineering Inc Class A | N/A | 4.58% | 30,400 |
| 9 | Sichuan Kelun Pharmaceutical Co Ltd Class A | N/A | 4.33% | 24,700 |
| 10 | ZLAB Zai Lab | $15.91
+1.1% | 4.11% | 3,143 |
| 11 | Genscript Biotech Corp Class H | N/A | 3.59% | 29,850 |
| 12 | Shenzhen Kangtai Biological Products Co Ltd Class A | N/A | 3.46% | 18,193 |
| 13 | Beijing Wantai Biological Pharmacy Enterprise Co Ltd Class A | N/A | 3.14% | 7,021 |
| 14 | 3SBio Inc Shs Unitary 144A/Reg S | N/A | 2.58% | 59,500 |
| 15 | BGI Genomics Co Ltd Class A | N/A | 2.58% | 6,538 |
| 16 | Daan Gene Co Ltd Class A | N/A | 2.07% | 31,380 |
| 17 | Joinn Laboratories (China) Co Ltd Class A | N/A | 1.95% | 10,506 |
| 18 | Anhui Huaheng Biotechnology Co Ltd Class A | N/A | 1.74% | 3,073 |
| 19 | Guangzhou Wondfo Biotech Co Ltd Class A | N/A | 1.43% | 8,200 |
| 20 | Pacific Shuanglin Bio-pharmacy Co Ltd Class A | N/A | 1.41% | 10,700 |
| 21 | China Animal Husbandry Industry Co Ltd Class A | N/A | 1.31% | 16,300 |
| 22 | Liaoning Chengda Biotechnology Co Ltd Class A | N/A | 1.29% | 5,878 |
| 23 | Beijing SL Pharmaceutical Co Ltd Class A | N/A | 1.27% | 20,500 |
| 24 | CanSino Biologics Inc Class A | N/A | 1.13% | 1,981 |
| 25 | Ascentage Pharma Group International | N/A | 0.95% | 7,000 |
| 26 | Chengdu Kanghua Biological Products Co Ltd Class A | N/A | 0.83% | 2,150 |
| 27 | Xiamen Amoytop Biotech Co Ltd Class A | N/A | 0.71% | 3,049 |
| 28 | Getein Biotech Inc Class A | N/A | 0.70% | 8,520 |
| 29 | Alphamab Oncology Ordinary Shares | N/A | 0.69% | 13,100 |
| 30 | Chengdu Olymvax Biopharmaceuticals Inc Class A | N/A | 0.67% | 5,567 |
| 31 | Shanghai ZJ Bio-Tech Co Ltd Class A | N/A | 0.62% | 3,845 |
| 32 | Hebei Changshan Biochemical Pharmaceutical Co Ltd Class A | N/A | 0.58% | 17,600 |
| 33 | Wuhan Keqian Biology Co Ltd Class A | N/A | 0.51% | 3,460 |
| 34 | Nanjing Vazyme Biotech Co Ltd Class A | N/A | 0.48% | 2,379 |
| 35 | Beijing Bohui Innovation Biotechnology Group Co Ltd Class A | N/A | 0.46% | 12,700 |
| 36 | Hualan Biological Bacterin Inc Class A | N/A | 0.46% | 2,050 |
| 37 | Shenzhen Weiguang Biological Products Co Ltd Class A | N/A | 0.39% | 1,600 |
| 38 | Frontier Biotechnologies Inc Class A | N/A | 0.32% | 4,399 |
| 39 | Jacobio Pharmaceuticals Group Co Ltd Ordinary Shares | N/A | 0.28% | 10,500 |
| 40 | Kintor Pharmaceutical Ltd Ordinary Shares | N/A | 0.23% | 10,300 |
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad) If you think AI is big, then you have got to check out something I call Imperium…
By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details |
| 41 | Cash | N/A | 0.17% | 3,600 |
